Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

v2.4.0.8
Financial Instruments (Tables)
9 Months Ended
Sep. 27, 2014
Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract]  
Summary of Available-for-sale Securities
 
  
Total Fair
Value
 
Cash and
Cash
Equivalents
 
Short-Term
Marketable
Securities
 
Long-Term
Marketable
Securities
 
(In millions)
September 27, 2014
 
 
 
 
 
 
 
 
Cash
 
$
362

 
$
362

 
$

 
$

Level 1(1) (2)
  
 
 
 
 
 
 
 
Money market funds
 
$
27

 
$
27

 
$

 
$

Total level 1
  
$
27

 
$
27

 
$

 
$

Level 2(2) (3)
 
 
 
 
 
 
 
 
Commercial paper
  
$
504

 
$
251

 
$
253

 
$

Corporate bonds
  
45

 

 
45

 

Total level 2
  
$
549

 
$
251

 
$
298

 
$

Total
  
$
938

 
$
640

 
$
298

 
$

 
  
Total Fair
Value
 
Cash and
Cash
Equivalents
 
Short-Term
Marketable
Securities
 
Long-Term
Marketable
Securities
 
(In millions)
December 28, 2013
 
 
 
 
 
 
 
 
Cash
 
$
429

 
$
429

 
$

 
$

Level 1(1) (2)
  
 
 
 
 
 
 
 
Money market funds
 
$
21

 
$
19

 
$

 
$
2

Total level 1
  
$
21

 
$
19

 
$

 
$
2

Level 2(2) (3)
 
 
 
 
 
 
 
 
Commercial paper
  
$
599

 
$
421

 
$
178

 
$

Time deposits
  
50

 

 
50

 

Corporate bonds
  
88

 

 

 
88

Total level 2
  
$
737

 
$
421

 
$
228

 
$
88

Total
  
$
1,187

 
$
869

 
$
228

 
$
90

Financial Instruments Not Recorded at Fair Value on a Recurring Basis
 
September 27, 2014
 
December 28, 2013
 
Carrying
Amount
 
Estimated
Fair Value
 
Carrying
Amount
 
Estimated
Fair Value
 
(In millions)
Short-term debt (excluding capital leases)
$
97

 
$
98

 
$
55

 
$
55

Long-term debt (excluding capital leases)
$
2,100

 
$
2,149

 
$
1,986

 
$
2,132

Schedule of Derivative Instruments, Gain (Loss) in Statement of Operations
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 27,
2014
 
September 28,
2013
 
September 27,
2014
 
September 28,
2013
 
 
(In millions)
Foreign Currency Forward Contracts
 
 
 
 
 
 
 
 
Contracts designated as cash flow hedging instruments
 
 
 
 
 
 
 
 
Other comprehensive income (loss)
 
$
(3
)
 
$
3

 
$
1

 
$
(1
)
Research and development
 

 
(1
)
 
(2
)
 
(1
)
Marketing, general and administrative
 
(1
)
 

 
(2
)
 

Contracts not designated as hedging instruments
 
 
 
 
 
 
 
 
Other income (expense), net
 
$
(2
)
 
$
1

 
$
(2
)
 
$
(1
)
Schedule of Derivative Instruments in Balance Sheet
 
 
September 27,
2014
 
December 28,
2013
 
 
(In millions)
Foreign Currency Forward Contracts
 
 
 
 
Contracts designated as cash flow hedging instruments
 
$
(2
)
 
$
(3
)
Contracts not designated as hedging instruments
 
$
(1
)
 
$
(1
)
 
 
September 27,
2014
 
December 28,
2013
 
 
(In millions)
Interest Rate Swap Contracts
 
 
 
 
Contracts designated as fair value hedging instruments
 
$
(1
)
 
$